Ludovic Ménard, Danièle Taras, Aude Grigoletto, Valérie Haurie, Alexandra Nicou, et al.. In vivo silencing of Reptin blocks the progression of human hepatocellular carcinoma in xenografts and is associated with replicative senescence.: Reptin silencing blocks liver cancer progression.
INTRODUCTION
Hepatocellular carcinoma is the fifth most common cause of cancer in the world and the third most common cause of cancer mortality (1) . The identification of new therapeutic targets is essential in order to improve HCC therapy. Through a comparative study of the proteome of HCC with that of the peri-tumor liver, we identified the deregulation of a number of proteins (2) , and especially the overexpression of RuvBL2/Reptin (3) . Reptin is also known as TIP49b (4) , TIP48 (5) , Reptin52 (6) , Rvb2 (7) , TAP54β (8) , and ECP-51 (9) . It belongs to the AAA+ family of ATPases (reviewed in (10, 11) ) and shows a limited homology to the bacterial RuvB ATP-dependent DNA helicase. Reptin is required for the growth and viability of yeast (12) and is essential for the normal development of Zebrafish (13) , Xenopus (14) , and Drosophila (15) . Reptin is found in several high-molecular-weight complexes involved in chromatin remodeling, transcriptional regulation or DNA damage repair (7, 8, 16) . It also interacts with proteins playing key roles in oncogenesis, such as β-catenin (6, 17) , c-Myc (5) , and telomerase (18) .
We showed that Reptin overexpression was found in 75% of HCC and was associated with a poor prognosis (3) . We also found that in vitro depletion of Reptin with siRNAs led to tumor cell growth arrest and to apoptotic cell death, whereas Reptin overexpression increased tumorigenicity in xenografts experiments.
Although these findings strongly suggest that Reptin may be a target in HCC, they require in vivo validation. For instance, tumor cells in a three dimensional setting like within tumors are more resistant to apoptosis and to chemotherapeutic drugs than when cultured in vitro in two dimensions (reviewed in (19, 20) ), and might also respond differently to Reptin depletion. In this study, we thus used a conditional shRNA expression model that allows switching off Reptin expression in vivo within already established tumors, thus mimicking a therapeutic setting.
MATERIALS AND METHODS

Construction of cell lines with a conditional expression of Reptin shRNA
We previously generated HuH7 cells with conditional, doxycyclin-dependent, expression of a Reptin shRNA (21) . Hep3B human HCC cells were similarly engineered. The Reptin shRNA sequence was the R2 sequence previously described (3) . As a control, we used a shRNA targeting Firefly luciferase (GL2). shRNA sequences are shown in Table 1 .
Transient transfection of small interfering RNA (siRNA)
ThesiR1andsiR2siRNAstargetingReptinmRNAweredescribed (3).Theywerebought from Eurogentec (Searing, Belgium) and transfected using Lipofectamine (Invitrogen, CergyPontoise,France)atafinalconcentrationof125nM.Asacontrol,weusedtheGL2 sequencetargetingluciferase.
Western Blot
Samples were prepared in a radioimmunoprecipitation buffer (22) . Protein concentration was measured with a Bio-Rad assay (Marnes-la-Coquette, France). Samples were analyzed by western blot with a Reptin mouse monoclonal antibody (BD Biosciences Pharmingen, Erembodegem, Belgium) and an anti-β-actin antibody for normalization. The blots were incubated with a secondary fluorescent antibody and signals were acquired and quantified with the Odyssey system (Li-Cor Biosciences, Lincoln, NE).
Cell proliferation
Cells were seeded at a density of 50 000 per well in 12-well plates. Adherent cells were counted at various times with a Coulter counter (Beckman Coulter, Villepinte, France) in duplicate wells.
Apoptosis assays
We quantified caspase 3 activity with a colorimetric assay as described by the manufacturer (Chemicon, Temecula, CA).
TUNEL assay was performed with the In Situ Cell Death Detection kit (Roche, Meylan, France).
Senescence assays
For evaluating acid β-galactosidase activity, cells were trypsinized and equivalent numbers were deposited on glass slides using a Shandon cytospin (Thermo Scientific, Waltham, MA). β-galactosidase activity was measured using a kit from Cell Signaling Technology (Danvers, MA). The same protocol was used on tissue cryosections from xenografts.
For detection of senescence-associated heterochromatin foci (SAHF) (23), cells were fixed with methanol at -20°C for 10 minutes, DNA was stained with DAPI (Sigma, 0.5µg/ml) and cells were examined under a Zeiss Axioplan microscope.
Telomerase activity was evaluated using the Quantitative Telomerase Detection Kit (US Biomax) following instructions from the supplier.
RT-QPCR
Total RNA was extracted from cultured cells with Trizol (Invitrogen, Cergy Pontoise, France). Frozen xenografts samples were first disrupted in Trizol with a bead grinder (Retsch, Eragny sur Oise, France). Two micrograms of RNA were reverse-transcribed with Superscript III (Invitrogen) and 100 ng of random hexamers (Roche, Meylan, France). Five (Reptin) or 2.5 µl (RLP0) of a 50-fold dilution of cDNA were used as template. PCR mixes were made so that each 25 µl reaction contained 12.5 µl of iQ Sybr Green Supermix (Bio-Rad) with 200 nM sense and antisense gene primers and diluted cDNA template. Reactions were run on the Mx4000 Multiplex Quantitative PCR system (Stratagene, La Jolla, CA). Sequences of primers are in Table 2 . For use in xenografted tumors, they were designed, and verified, to be humanspecific.
Data analysis was performed with Mx4000 software (version 4.2, Stratagene). Gene expression results were first normalized to internal control RLP0 or β-actin. Relative levels of expression were quantified by the calculation of 2 -ΔΔCt (24) . The results were expressed as a ratio with respect to the expression level in GL2 cells without Dox.
Xenografts
Animals used were either non-obese diabetic-severe combined immunodeficiency mutation (NOD-SCID) (25) or NOD/SCID/γ c null (NOG) (26) mice. Mice aged 9 to 15 weeks were used.
The study was performed in accordance with the European Community Standards on the Care and Use of Laboratory Animals. Mice were injected subcutaneously with either 4.10 6 HuH7
(mixed with an equal volume of Matrigel, Becton Dickinson), or 3.10 6 Hep3B cells in the flank. Tumor size was monitored with calipers. Tumor volume was estimated as (
where D is the large diameter and d is the small diameter of the tumor. At the end of the experiment, tumors were divided into parts snap-frozen in liquid nitrogen, frozen in liquid nitrogen-cooled isopentane, or fixed in 10% neutral formalin.
Immunohistochemistry activated caspase 3 were detected using antibodies from Dako (M7240, 1/75) and R&D Systems (H1009, 1/200), respectively. The number of KI67-positive cells was measured relative to the total number of cells in 5 random fields examined under the 63X objective.
Statistical Analysis
Differences between means were assessed with analysis of variance (ANOVA). A P value less than 0.05 was considered significant.
RESULTS
Expression of a siRNA-resistant Reptin rescues the cell growth phenotype
We showed that transient transfection of 2 different siRNAs against Reptin reduced cell proliferation whereas a control siRNA had no effect (3) . Before conducting in vivo experiments, we performed an additional control in order to rule out possible off-target effects. We generated a Reptin cDNA harboring silent mutations in the siRNA targeting sequence that makes the mRNA insensitive to this siRNA (21) . We then assessed whether the siR2-resistant Flag-tagged Reptin was able to rescue the growth phenotype. Transient transfection of siR1 induced as expected a profound reduction in cell numbers whereas the growth of cells transfected with siR2 was indistinguishable from that of non transfected cells or cells transfected with the control siRNA ( Fig. 1D ).
Altogether, these data show that the effects of siR2 on cell growth are sequence-specific.
Conditional expression of Reptin shRNA
We used a conditional shRNA expression system (27) based on the expression of the tTR protein fused to the KRAB domain of human Kox1 (28) . KRAB is a transcriptional repression domain that represses all three RNA polymerases (29) . In the absence of Dox, tTR-KRAB binds specifically to tetO sequence and suppresses the activity of the nearby promoter. In the presence of Dox, tTR-KRAB does not bind the tetO sequence, thus allowing gene expression (28) . Here, shRNA sequences are under the control of the polymerase III-dependent H1
promoter itself under the control of the tetO sequence. A cassette containing the GFP reporter gene under the control of the ubiquitously active mammalian EF1α promoter is located upstream the tetO sequence. Consequently, GFP expression is also under the control of tTR-
KRAB.
We first checked that the cell lines expressed the transgenes in a Dox-dependent manner. No cells detectably expressed GFP in the absence of Dox, indicating the tightness of the transcriptional repression (Fig 2A) . With 0.002 µg/ml Dox, 31 (GL2) or 46% (R2) of cells were GFP-positive, whereas up to 90% of cells expressed detectable amounts of GFP with 0.016 µg/ml of Dox or higher. This indicates that a vast majority of cells have integrated the lentiviral genome and consequently GL2 or R2 shRNA.
We then used quantitative RT-PCR to measure Reptin transcript levels. At 72 hours after Dox treatment, as compared to untreated GL2 cells, Reptin mRNA levels were reduced to 28.2% ± 20.2% in R2 cells versus 102.6 % ± 6.0 % in R2 cells not treated with Dox (n=3, p<0.01) ( Fig   2B) . There was no difference between Reptin mRNA levels in GL2+Dox versus GL2-Dox.
Finally, we measured Reptin protein expression by western blot (Fig. 2C) . The results were parallel to those of GFP expression, with a maximal decrease of more than 80% with concentrations ≥ 0.016 µg/ml Dox. In the GL2 cell line, no change in Reptin expression was observed with or without Dox. In the following experiments, we used the concentration of 0.016µg/ml Dox.
We noticed that the Reptin/actin ratio increased over time in GL2 cells, in the absence or in the presence of Dox ( Fig 2D) , as well as in un-transduced cells. This was not observed in the were highly significant (p<0.0001; Fig 3A) . Similar results were obtained with the Hep3B cell lines (Fig. 3B) .
Consistent with our previous study (3) , the decrease in cell growth was due in part to increased apoptosis. Indeed, caspase 3 activity was significantly increased in R2+Dox cells in comparison to control cells (p<0.001; Fig. 3C ).
In addition, we also tested whether Reptin knock-down resulted in increased cell senescence.
Acid β-galactosidase activity was indeed found in a much larger number of cells in the R2+Dox condition than in the 3 other groups (Fig. 3D ). Most positively stained cells also exhibited a larger size than other cells, an additional argument for a senescent phenotype.
Moreover, the staining of nuclear DNA showed characteristic SAHF in nuclei of R2+Dox cells ( Fig 3E) . Lastly, telomerase activity was reduced in R2+Dox as compared to R2-Dox cells (4.7 and 6.9 fold in 2 separate experiments conducted in triplicate in cells grown for 5 days with or without Dox).
Conditional silencing of Reptin reduces tumor growth in xenografts.
To test if Reptin expression is necessary for tumor growth in vivo, we inoculated NOD-SCID mice (30) with the GL2 or R2 HuH7 cell lines. When the tumor volume reached 250 mm 3 , mice were randomly assigned to receive either Dox (2 mg/mL in drinking water with 5% sucrose), or only sucrose.
Starting from Day 4 after administration of Dox, the mean tumor volume in R2+Dox animals did not progress until the end of the experiment, in contrast with the R2-Dox animals in which it progressed steadily (p <0.0001) ( Fig 4A) . The decrease in tumor growth of R2+Dox animals was not due only to the Dox treatment as evidenced by the similar progression of tumors in GL2-Dox and GL2+Dox animals. Similar results were obtained with xenografts of Hep3B cells. In that case, whereas animals from all three control groups had to be sacrificed for ethical reasons because of progressive tumor growth, R2+Dox tumors soon stopped growing and some eventually completely regressed when treatment was further prolonged ( Fig. 4B ).
We used immunohistochemistry in explanted tumors to confirm that reduced tumor growth correlated with silencing of Reptin expression, Reptin staining was intense in tumor cells from GL2-Dox, GL2+Dox or R2-Dox groups, whereas it was almost absent in R2+Dox tumors (Fig. 4C ).
Mechanisms of anti-tumor effects in vivo
Because explanted tumors at the end of the above experiment were very much remodeled and exhibited large areas of necrosis, it was not feasible to quantify accurately cell proliferation, apoptosis or senescence. We thus repeated the experiment with HuH7 cells in another series of mice that were sacrificed after only 8 days on Dox treatment. This experiment again demonstrated the striking effect of Reptin silencing, leading to a complete arrest in tumor progression ( Fig. 5A ). RT-PCR confirmed the drastic decrease in Reptin transcripts in R2+Dox tumors (Fig. 5B ). Reptin staining in explanted tumors was also considerably decreased in R2+Dox tumors (Fig. 5C ) where only some nuclear staining persisted (See inset at higher magnification. From in vitro experiments, we noticed that shRNAs depleted more rapidly cytoplasmic than nuclear Reptin, not shown).
Control tumors (GL2±Dox, R2-Dox) exhibited a massive Ki67 staining, which was significantly reduced in R2 + Dox tumors ( Fig. 5C -D, p = 0.0038).
The mean number of TUNEL-positive cells in R2+Dox tumors was 6.9 ± 1.6 per microscopic field, not significantly different from that in R2-Dox tumors (4.8 ± 1.9). Immunostaining for activated caspase 3 did not either reveal differences between groups (not shown). In addition,
Bad and Bak mRNA levels in explanted tumors were not increased in R2+Dox tumors (Fig.   5E ).
Staining for acid β-galactosidase activity was scarcely seen in control tumors whereas every R2+Dox tumor exhibited many positive cells, often in foci (Fig. 5C ). In addition DAPI staining showed a large number of cells with SAHF in R2+Dox tumor sections ( Fig. 5C ). The number of cells with SAHF counted in 3 random microscopic fields was 29.0 ± 8.7 and 1.8 ± 0.2/field in R2+Dox and R2-Dox tumors, respectively (p = 0.03, n = 4).
DISCUSSION
We previously showed that overexpression of Reptin was found in the vast majority of HCC and correlated with a poor prognosis. In addition, experimental evidence suggested that
Reptin played a role in hepatocarcinogenesis and was a potential therapeutic target (3) . It remained however to be shown that targeting Reptin in established tumors had a therapeutic effect.
The constitutive expression of shRNA is commonly used for the study of the loss of function of a protein, but it is a major problem when the targeted gene is essential for the survival of cells. In order to circumvent this problem, several inducible shRNA systems have been developed, relying either on inducers such as tetracycline or its derivatives (27, 31, 32) , or on the Cre-LoxP system (33) . To date, however only a few recent studies have used these tools to demonstrate the role of a protein in tumor progression, especially in a therapeutic-type situation, i.e., when tumors were already established (34) (35) (36) (37) .
Here, we studied the impact of a decreased expression of Reptin on tumor growth in a xenograft model in mice. We first took great care to ensure of the specificity of the siRNA targeting sequence. In addition to previous control experiments (3), we thus used a rescue strategy, and we used a luciferase siRNA as an additional control. Altogether, these experiments allowed to conclude with a high level of confidence that the effects of the siR2 targeting sequence were very specific according to published guidelines (38) .
For in vivo experiments, we engineered HuH7 and Hep3B human HCC cell lines conditionally expressing Reptin shRNA in a Dox-dependent manner (27) . In vitro studies showed that expression of the Reptin shRNA recapitulated our findings with transient transfection of siRNA, like cell growth inhibition and increased apoptosis (3) . In addition, we made the new finding that Reptin silencing also increased the occurrence of cell senescence.
Reptin participates in the TIP60 complex together with p400, a member of the SWI2/SNF2 chromatin-remodeling family (8). Chan et al. observed that p400 or Reptin knock-down resulted in cell senescence in fibroblasts (39) . This was not tested in tumor cells. However, they found that p400 knock-down did not induce senescence in cells with mutated p53. HuH7
have one deleted p53 allele and a codon 220 mutation in the other, resulting in a stabilized protein, albeit with a loss of transcriptional activity (40) . Thus p53 inactivation does not preclude the induction of senescence by Reptin depletion, suggesting that its mechanism may differ from that due to p400 depletion. The induction of senescence with Reptin extinction is in agreement with the recent demonstration that Reptin is required for telomerase activity (18) , a finding that was also observed in our model.
We injected transduced cell lines to mice. When tumors reached a predefined volume, we induced the transcription of shRNAs by administering Dox. This led to a large decrease in Reptin expression in vivo, only in R2+Dox animals. Reptin depletion was associated with a striking inhibition of the tumor growth. Indeed, the progression of these tumors almost completely stopped a few days following Dox treatment. In the case of Hep3B-derived tumors, a more prolonged treatment even led to a complete regression of some tumors.
Although apoptosis was clearly detectable in HuH7 cells in vitro 6 days following Reptin shRNA induction, none was observed in vivo after 8 days even though Reptin was effectively silenced and tumor growth had already stopped. It is possible that in vivo, tumor cells are somehow protected from apoptosis due to Reptin depletion because of the three-dimensional architecture and of the presence of the tumor stroma that conveys protective signals (19, 20) .
However, reduced tumor progression was associated with reduced cell proliferation and induction of senescence. We suggest that Reptin silencing, likely through inhibition of telomerase activity, induces cell senescence resulting in inhibition of cell proliferation.
Because Hep3B tumors eventually regressed, it is however likely that apoptosis occurred secondarily.
Our results may have therapeutic relevance because, even though using siRNAs for the treatment of cancer is still a remote prospect, targeting the ATPase activity of Reptin with drugs may be accessible. Circumstantial evidence suggests that this enzymatic activity is required for oncogenesis. Indeed, mutations that abolish ATPase activity of the yeast homologue of Reptin suppresses the growth of the yeast S. cerevisiae (4, 12) , whereas an
ATPase activating mutation has growth-promoting effects in the Zebrafish (41) . In addition, ATPase deficient mutants of the related protein Pontin impair the transforming activity of βcatenin (42) or of c-myc (5) . Capital letters indicate the targeting sequences. with siR1 significantly decreased cell numbers at Day 5 (p = 0.01) and Day 6 (p = 0.004).
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Figure 2. GFP and Reptin expression in GL2 and R2 cell lines after treatment with Dox.
A, GL2 and R2 cell lines were exposed during 72 hours to the indicated concentrations of 
